Mr Antoine Vergnat > McDermott Will & Emery AARPI > Paris, France > Lawyer Profile
McDermott Will & Emery AARPI Offices
23 RUE DE L'UNIVERSITÉ
- Go to...
Mr Antoine Vergnat
Partner Antoine Vergnat focuses his practice on advice to French and non-French investment funds, corporate groups and entrepreneurs operating in the industrial, service and real estate sectors on a broad range of domestic and international tax matters. Antoine focuses his practice on transactional tax law, with an emphasis on matters relating to the acquisition and sale of assets, the financing and restructuring of groups, as well as the management of tax affairs and controversies before tax authorities.
Antoine also regularly provides tax advice to high-net-worth individuals on a broad range of domestic and international tax matters and has significant experience in the structuring of equity compensation schemes for management teams.
For further details of Antoine’s biography, please view McDermott website here.
EDHEC Business School, 1996
University of Paris-Dauphine, LLM (DESS), Corporate Taxation, 1999
University of Paris I Panthéon-Sorbonne, Master’s, Tax Law, 1998
Dirigée par Antoine Vergnat, l’équipe de McDermott Will & Emery AARPI est recommandée pour sa forte expertise en matière de fiscalité transactionnelle des opérations de fusions-acquisitions et de private equity. Elle intervient dans la plupart des opérations traitées par le cabinet. L’équipe assiste régulièrement des fonds d’investissement ainsi que des groupes pharmaceutiques et de santé. Elle est en capacité de traiter des dossiers fiscaux internationaux, intégrant notamment une forte composante américaine. Enfin, le champ d’expertise couvre les deals de marchés de capitaux, les dossiers de restructuration fiscale et la gestion du contentieux.
Led by Antoine Vergnat, McDermott Will & Emery AARPI‘s tax practice has particular strength in advising on the structuring of M&A and private equity transactions in which the firm is involved. The team assists investment funds and several pharmaceutical and healthcare companies. It is adept at handling cross-border tax matters, often involving a US component, and has expertise in capital markets deals. The team also provides standalone tax advice to companies on tax restructuring and litigation.